Bicara Therapeutics (NASDAQ:BCAX) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to outline its ...

Peer-reviewed discovery platform and data in PNAS show that single transcription factor modulation reverses aging-associated gene expression and restores healthy cellular and tissue function in models ...

Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral ...

The transparent wood is not only promising for indoor illumination and a healthy lifestyle, but also protects privacy at ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.

Anti-inflammatory treatment reduced depressive symptoms and anhedonia in patients with elevated inflammation. Learn more.

Sam Ash has updated its inventory and is now offering the Sequential Prophet-5 Synthesizer as part of its collection of ...

Environmentally friendly buildings are highly attractive for sustainable development and efficient energy consumption. Recently, scientists have made ...

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies ...

$11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnouts Vivasure Medical Limited (“Vivasure”) has been a strategic ...

Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...